|
Section g4: there was no patient involved in this event.The pma # provided is associated with the device¿s most recent approval.Section h6: health effect - impact code corrected.Manufacturer's investigation conclusion: although the reported sound and condensation were unable to be conclusively confirmed, functional testing of the returned oxygenator by the manufacturer (eurosets) found that the device was compliant with the technical specifications.The oxygenator was returned to abbott where an initial visual inspection was performed.Visual inspection of the oxygenator revealed no obvious damage.It was noted that some drops of fluid were in the top housing, which could be indicative of the reported condensation.The oxygenator was forwarded to the external manufacturer (eurosets) for technical analysis.A functional test of the oxygenator was performed on a test circuit with bovine blood and found that the oxygenator was compliant with the reference values.The claimed condensation was not found during the technical investigation.Eurosets confirmed that condensation is a normal condition that could have happened during priming and treatment due to change in temperature between the environment and inside of the extracorporeal membrane oxygenation (ecmo) device.Eurosets determined that the safety of the patient is not involved, and the performance of the device is guaranteed.Eurosets concluded that the technical investigation confirmed that the claimed device was compliant with the technical specification and for that reason they were not able to confirm the complaint by the customer.Eurosets communicated that this event will be monitored within the eurosets trend reporting and in case of adverse trends, further investigation and/or corrective actions will be carried out.The production documentation for the eurosets oxygenator, lot number 7896808, was reviewed by the external manufacturer (eurosets) and showed that all tests made in the production process were compliant with the technical specifications.The eurosets amg pmp instructions for use (ifu), rev.05, is currently available.Under the list of warnings, the ifu warns that during use, a spare oxygenator must always be available and warns that the device has to be carefully and continuously checked by qualified healthcare professionals throughout the procedure.Under the section titled ¿oxygenator replacement¿, this document states that a spare oxygenator must always be available during perfusion.After 6 hours of use with blood or if particular situations occur, which may lead the person responsible for perfusion to determine the safety of the patient may be compromised (insufficient oxygenator performance, leaks, abnormal blood parameters, etc.), follow the procedure outlined in the ifu for oxygenator replacement.No further information was provided.The manufacturer is closing the file on this event.
|